9 Meters Biopharma, Inc. (NMTR) Financial Statements
9 Meters Biopharma, Inc. (NMTR) files with the U.S. Securities and Exchange Commission under CIK 0001551986. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2022
- Net Income
- -$43.77 million
- Total Assets
- $33.15 million
- Net Cash from Operations
- -$37.24 million
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: May 15, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for NMTR in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History